FIELD: medicine, pharmaceutics.
SUBSTANCE: what is presented is an agent of diuretic action of a group of aquaretics, phenyl-α-O-D- glucopyranoside. The agent may be used both to treat greater and lesser circulation congestions caused by cardiac failure, and to intensify water release thereby helping to reduce oedemas. The agent has high and low saluretic activity unlike the existing diuretics and expands the range of products of synthetic origin possessing diuretic activity.
EFFECT: agent is applicable for treating the number of cardiovascular diseases accompanied by excessive hydration and developing oedema syndrome.
1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| DIURETIC AGENT | 2012 |
|
RU2484826C1 |
| MEDICATION, POSSESSING DIURETIC ACTION | 2012 |
|
RU2517091C2 |
| DIURETIC AGENT | 2012 |
|
RU2500407C2 |
| MEDICATION POSSESSING DIURETIC ACTIVITY | 2009 |
|
RU2416404C1 |
| AGENT HAVING DIURETIC AND ANTI-INFLAMMATORY ACTION | 2013 |
|
RU2522925C1 |
| HERBAL REMEDY WITH DIURETIC AND NATRIURETIC ACTIVITY FOR THE PREVENTION AND TREATMENT OF DISEASES OF THE URINARY SYSTEM | 2022 |
|
RU2791782C1 |
| DIURETIC | 2009 |
|
RU2408367C1 |
| USE OF HYPEROZIDE AS A DIURETIC, SALURETIC AND CREATININURETIC AGENT | 2022 |
|
RU2802832C1 |
| USE OF QUERCETIN AS A DIURETIC, SALURETIC AND CREATININURETIC AGENT | 2022 |
|
RU2802833C1 |
| USE OF DIHYDROQUERCETIN AS A DIURETIC, SALURETIC AND CREATININURETIC AGENT | 2022 |
|
RU2802874C1 |
